Where can I find news about BVC?

The latest headlines, third-party analysis, and SEC filings for BitVentures Limited (BVC) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are BVC's SEC filings?

BitVentures Limited (BVC)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are BVC's earnings call transcripts?

Full earnings call transcripts for BitVentures Limited (BVC), with prepared remarks plus speaker-by-speaker analyst Q&A, live on the Earnings tab alongside the Earnings Reports section that links each quarter's press release and SEC report.

BVC

BitVentures Limited

NASDAQ·Software, Application · Technology

$14.05$1.60+12.85%

Market cap$2.36B·Market closed·Oct 23 4:00 PM EDT

News & Analysis

Bitventures Ltd (NASDAQ:BVC) Stock Short Interest Climbs 159.9%
Bitventures Ltd (NASDAQ: BVC - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 2,973 shares, an increase of 159.9% from the August 31st total of 1,144 shares. Based on an average daily volume of 45,082 shares, the
defenseworld.netSep 28, 2026 · 9:41 AM
BATM Advanced Communications: A growth opportunity at the cutting edge of technology
BATM Advanced Communications Ltd (LSE:BVC), a London-listed technology innovator, is making headlines with progress in its diagnostics division. Its NATlab platform, developed by associate company ADOR Diagnostics, has begun pre-clinical validation at Rome's Lazzaro Spallanzani National Institute for Infectious Diseases.
proactiveinvestors.co.ukDec 11, 2024 · 8:13 AM
BATM Advanced Communications makes major step forward with diagnostic
BATM Advanced Communications Ltd (LSE:BVC) has announced a major step forward in the development of its NATlab diagnostic platform, which has begun pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome. This follows successful trials in Israel, confirming the system's effectiveness in identifying infectious diseases quickly and accurately.
proactiveinvestors.co.ukDec 11, 2024 · 2:47 AM

SEC Filings

6-K
Apr 20, 2026View on SEC
SC 13D/A
Feb 27, 2026View on SEC
8-A12B/A
Jan 7, 2026View on SEC
6-K
Jan 7, 2026View on SEC
6-K
Jan 2, 2026View on SEC
6-K
Dec 30, 2025View on SEC

Frequently Asked Questions About BVC

Where can I find news about BVC?: The latest headlines, third-party analysis, and SEC filings for BitVentures Limited (BVC) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are BVC's SEC filings?: BitVentures Limited (BVC)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are BVC's earnings call transcripts?: Full earnings call transcripts for BitVentures Limited (BVC), with prepared remarks plus speaker-by-speaker analyst Q&A, live on the Earnings tab alongside the Earnings Reports section that links each quarter's press release and SEC report.

BitVentures Limited

Frequently Asked Questions About BVC

BitVentures Limited

Bitventures Ltd (NASDAQ:BVC) Stock Short Interest Climbs 159.9%

BATM Advanced Communications: A growth opportunity at the cutting edge of technology

BATM Advanced Communications makes major step forward with diagnostic

Frequently Asked Questions About BVC

Bitventures Ltd (NASDAQ:BVC) Stock Short Interest Climbs 159.9%

BATM Advanced Communications: A growth opportunity at the cutting edge of technology

BATM Advanced Communications makes major step forward with diagnostic